Skyward Specialty Insurance's general counsel sells $38,005 in stock

Published 07/01/2025, 01:32
Skyward Specialty Insurance's general counsel sells $38,005 in stock

Shaunty Leslie, the General Counsel and Secretary of Skyward Specialty Insurance Group, Inc. (NASDAQ:SKWD), recently executed stock transactions as disclosed in an SEC filing. On January 3 and January 6, Leslie sold a total of 801 shares of common stock, generating proceeds of $38,005. The sales were conducted at prices ranging from $47.072 to $47.731 per share. The transactions come as the company, currently valued at $1.86 billion, has seen its stock decline nearly 11% in the past week, though maintaining a robust 26% gain over the last six months.

These transactions were carried out under a pre-established Rule 10b5-1 trading plan, adopted on August 8, 2024. The shares sold were part of a Restricted Stock Award granted to Leslie, which fully vested on January 1, 2025. According to InvestingPro analysis, SKWD maintains strong financial health with liquid assets exceeding short-term obligations and trades at an attractive P/E ratio of 16.4. The sales were made to cover taxes and fees associated with the vesting event. Following these transactions, Leslie holds 20,407 shares of Skyward Specialty Insurance Group. For deeper insights into SKWD's valuation and 8 additional ProTips, visit InvestingPro.

In other recent news, Piper Sandler has shown continued confidence in Palomar Holdings (NASDAQ:PLMR) and Skyward Specialty Insurance Group, two companies with significant reliance on reinsurance. For Palomar, the firm's analyst, Paul Newsome, raised the price target to $133 from $119, maintaining an Overweight rating. This change was based on an estimated 19 times the projected earnings per share (EPS) of $6.80 for 2026, suggesting confidence in the company's growth potential and earnings capabilities. However, potential risks were noted, including Palomar's focus on niche lines of business that could be affected by changes in competition and regulatory adjustments.

Similarly, Piper Sandler raised its price target for Skyward Specialty Insurance Group to $58 from $54, also maintaining an Overweight rating. The revised target reflects an increased earnings multiple from 15.0x to 16.0x based on the firm's forward (2026E) earnings estimate of $3.60 per share. Skyward Specialty's positive performance in the recent year, with strong revenue growth of 32.05%, justified this adjustment.

In other developments, Skyward Specialty secured a $57 million loan from the Federal Home Loan Bank of Dallas and formed a strategic joint venture with Bishop Street Underwriters, a subsidiary of RedBird Capital Partners (WA:CPAP). Other firms, including Keefe, Bruyette & Woods, BMO Capital Markets, and JMP Securities, have also revised their price targets for Skyward Specialty upward following strong Q2 earnings and revenue.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.